UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 167

Sortiert nach

Concise Review: Mesenchymal Stem Cells for Acute Lung Injury: Role of Paracrine Soluble Factors

Stem cells (Dayton, Ohio), 2011-06, Vol.29 (6), p.913-919

2011

Volltextzugriff (PDF)

Actin‐binding protein filamin A is displayed on the surface of human neuroblastoma cells

Cancer science, 2006-12, Vol.97 (12), p.1359-1365

2006

Volltextzugriff (PDF)

Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study

Gynecologic oncology, 2015-10, Vol.139 (1), p.17-22

2015

Volltextzugriff (PDF)

Drivers of Medicare Spending: A 15-Year Review of Radiation Oncology Charges Allowed by the Medicare Physician/Supplier Fee-for-Service Program Compared With Other Specialties

International journal of radiation oncology, biology, physics, 2021-06, Vol.110 (2), p.322-327

2021

Volltextzugriff (PDF)

Pyruvate Kinase M1 Suppresses Development and Progression of Prostate Adenocarcinoma

Cancer research (Chicago, Ill.), 2022-07, Vol.82 (13), p.2403-2416

2022

Volltextzugriff (PDF)

Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) Study

Journal of clinical oncology, 2020-01, Vol.38 (3), p.214-222

2020

Volltextzugriff (PDF)

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

The New England journal of medicine, 2023-04, Vol.388 (17), p.1547-1558

2023

Volltextzugriff (PDF)

Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial

JAMA oncology, 2021-03, Vol.7 (3), p.421

2021

Volltextzugriff (PDF)

Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405

Journal of clinical oncology, 2019-10, Vol.37 (29), p.2620-2631

2019

Volltextzugriff (PDF)

First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer

Journal of clinical oncology, 2017-10, Vol.35 (30), p.3391-3400

2017

Volltextzugriff (PDF)

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer

Journal of clinical oncology, 2016-07, Vol.34 (20), p.2325-2332

2016

Volltextzugriff (PDF)

Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study

The lancet oncology, 2018-04, Vol.19 (4), p.486-496

2018

Volltextzugriff (PDF)

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

The New England journal of medicine, 2017-02, Vol.376 (5), p.417-428

2017

Volltextzugriff (PDF)

Comparison of Bayesian penalized likelihood reconstruction versus OS-EM for characterization of small pulmonary nodules in oncologic PET/CT

Annals of nuclear medicine, 2017-10, Vol.31 (8), p.623-628

2017

Volltextzugriff (PDF)

Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer

Cancer Immunology, Immunotherapy, 2010-05, Vol.59 (5), p.663-674

2010

Volltextzugriff (PDF)

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers

Journal of clinical oncology, 2019-04, Vol.37 (12), p.946-953

2019

Volltextzugriff (PDF)

2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines

Journal of clinical oncology, 2000-10, Vol.18 (20), p.3558-3585

2000

Volltextzugriff (PDF)

Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US

JAMA oncology, 2024-03, Vol.10 (3), p.342

2024

Volltextzugriff (PDF)

FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer

Breast cancer research : BCR, 2023-08, Vol.25 (1), p.99-99, Article 99

2023

Volltextzugriff (PDF)

NRG1 Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in KRAS Wild-Type Pancreatic Ductal Adenocarcinoma

Clinical cancer research, 2019-08, Vol.25 (15), p.4674-4681

2019

Volltextzugriff (PDF)

1 – 25 von 167

Suche als RSS-Feed

Aktive Filter

ThemaTreatment Outcome

ThemaLife Sciences & Biomedicine

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(160)
Mit Volltextzugriff
(152)

Publikationsform

Artikel
(167)

Sprache

Englisch
(167)
Japanisch
(29)

Erscheinungsjahr

n.n

Thema

Science & Technology
(167)
Humans
(135)
Female
(82)
Male
(72)
Middle Aged
(69)
Aged
(67)
Biological And Medical Sciences
(63)
Medical Sciences
(63)
Adult
(55)
Tumors
(36)
Pharmacology. Drug Treatments
(31)
Antineoplastic Agents
(28)
Chemotherapy
(27)
Aged, 80 And Over
(24)
Prognosis
(23)
Radiology, Nuclear Medicine & Medical Imaging
(23)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(21)
Medicine
(19)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Concise Review: Mesenchymal Stem Cells for Acute Lung Injury: Role of Paracrine Soluble Factors

Actin‐binding protein filamin A is displayed on the surface of human neuroblastoma cells

Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study

Drivers of Medicare Spending: A 15-Year Review of Radiation Oncology Charges Allowed by the Medicare Physician/Supplier Fee-for-Service Program Compared With Other Specialties

Pyruvate Kinase M1 Suppresses Development and Progression of Prostate Adenocarcinoma

Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) Study

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial

Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405

First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer

Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial

Comparison of Bayesian penalized likelihood reconstruction versus OS-EM for characterization of small pulmonary nodules in oncologic PET/CT

Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma

Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers

Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines

Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US

FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer

NRG1 Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in KRAS Wild-Type Pancreatic Ductal Adenocarcinoma

Aktive Filter

Suchergebnisse filtern